Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Sunday Times (Johannesburg) - February 10, 2009
Teneshia Naidoo and Nivashni Nair
But clinical trials of the Pro 2000 microbicidal gel showed only 30 percent efficacy in preventing the transmission of sexually transmitted diseases.
Though 33 percent efficacy is needed for a study to be declared statistically successful, the trials are considered significant.
The study, by the HIV prevention unit of the Medical Research Council, found that the risk of infection in women who used the vaginal gel was reduced by a third compared with women using an unmedicated product or not using a gel.
The director of the unit, Professor Gita Ramjee, said: "After working for more than a decade in microbicide research, we are seeing a glimmer of hope of finding a safe and effective microbicide, which could protect women and substantially reduce HIV infection."
Tests were done on 3050 women in the US, Malawi, Zimbabwe, Zambia and South Africa. The results were released simultaneously yesterday at Durban's RK Khan Hospital and at the Conference on Retroviruses and Opportunistic Infections, in Canada.
The Gender Advocacy Programme said women should treat the results of the study with caution, but a gel that reduced the HIV infection rate would radically alter women's rights in sexual relationships.
"With something like the gel, which they can use by themselves, women are at an advantage. But they must not be recklessly over-confident in a gel. The safest sex is with a condom, or abstinence," the programmes's spokesman, Raashied Galant, said.
090210
ST090203
Copyright © 2009 - The Sunday Times. Reproduction of this article (other than one copy for personal reference) must be cleared through the Sunday Times Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .